Effect of early hypolipidemic therapy of different intensity on endothelial function in patients with acute myocardial infarction with ST segment elevation

Main Article Content

O. M. Parkhomenko
A. O. Stepura
Y. M. Lutay
O. I. Irkin
D. O. Bilyi


The aim – to evaluate the effect of different hypolipidemic therapy on changes in endothelial function in patients with acute myocardial infarction with ST segment elevation (STEMI).
Materials and methods. The study enrolled 135 patients with STEMI within the 12 hours of symptoms onset (average 4.7±1.0) who were admitted to the intensive care unit at NSC «M.D. Strazhesko Institute of Cardiology». Patients were distributed into 4 groups by envelope method. At the enrolment to the hospital patients were prescribed hypolipidemic therapy till the procedure of revascularization – percutaneous coronary intervention. The first (1st) group included 26 pts who were prescribed a combination of atorvastatin (10 mg) and ezetimibe (10 mg). The second (2nd) group included 24 pts, who were prescribed atorvastatin at a dose of 40 mg. The third (3rd) group included 43 pts, who received 80 mg of atorvastatin, the fourth (4th) group included 42 pts who were prescribed a combination of atorvastatin 40 mg and ezetimibe 10 mg. Basic therapy was formed according to the current guidelines of the European Society of Cardiologists and the National Diagnostic Protocols. The selected groups did not have difference in clinical and anamnestic characteristics and methods of treatment. Determination of reactive hyperemia using flow-dependent vasodilatation (FDV) was performed on the 1st and 10th days of the hospital period and within the 90th day of onset of the disease onset.
Results and discussion. Prescription of high-intensity lipid-lowering therapy using 80 mg of atorvastatin (group 3) and 40 mg of atorvastatin and 10 mg of ezetimibe (group 4) caused a greater lipid-lowering effect compared to the medium-intensity therapy (group 1 and 2) in the dynamics of observation. Group 3 patients experienced a significant decrease in low-density lipoprotein cholesterol (LDL cholesterol) on the 10th and 90th days, and its decrease reached values ​​below the recommended values ​​(up to 1.75±0.11 mmol/L. In group 4 on we recorded a significant decrease in LDL cholesterol on the 10th day and by the 90th day it was 1.55 mmol/L. The mean LDL cholesterol level below the target was only reached in groups 3 and 4. Normalization of endothelial function (FDV greater than 10 %) was significantly more frequently observed in patients who reached less than 1.8 mmol/L by the 90th day of target LDL cholesterol.
Conclusions. For the normalization of endothelial function (increase in FDV) during hypolipidemic therapy in patients undergoing STEMI, it is necessary to achieve the target values ​​of LDL cholesterol up to 90 days of the disease, which is possible only when conducting high-intensity hypolipidemic therapy. The absence of improvement in endothelial function during observation in a constant number of patients suggests that there may be additional, possibly genetic, factors that are not affected by the treatments used.

Article Details


acute coronary syndrome, acute myocardial infarction, endothelium, hypolipidemic therapy, atorvastatin, ezetimibe


Лутай Я.М., Пархоменко О.М., Степура А.О. та ін. Кліні­­­ко-прогностичне значення результатів проби з потік-залежною вазодилатацією у хворих із гострим коронарним синдромом з елевацією сегмента ST // Медицина невідкладних станів.– 2014.– № 3 (58).– С. 35–44. doi: http://nbuv.gov.ua/UJRN/Medns_2014_3_8.

Лутай Я.М., Пархоменко О.М., Рижкова Н.О. та ін. Вплив терапії внутрішньовенним інгібітором 5-ліпоксигенази кверцетином на функцію ендотелію, вираженість системного запалення та прооксидантного стресу при гострому інфаркті міокарда з елевацією ST // Медицина невідкладних станів.– 2016.– № 1 (72).– С. 111–119. doi: http://nbuv.gov.ua/UJRN/Medns_2016_1_19.

Мойбенко О.О., Сагач В.Ф., Шаповал Л.М. та ін. Роль ендотелію та біологічно активних речовин ендотеліального походження в регуляції кровообігу і діяльності серця // Фізіол. журн.– 1997.– № 43 (1/2).– С. 3–18.

Anderson T.J., Gerhard M.D., Meredith I.T. et al. Systemic nature of endothelial dysfunction in atherosclerosis // Am. J. Cardiol.– 1995.– Vol. 75 (6).– P. 71B–74B. https://doi.org/10.1016/0002-9149(95)80017-m. Brunner H., Cockcroft J.R., Deanfield J. et al. Endothelial function and dysfunction. Part II: Association with cardio­­vascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension // J. Hypertens.– 2005.– Vol. 23 (2).– P. 233–246. https://doi.org/10.1097/00004872-200502000-00001.

Cannon C.P., Blazing M.A., Giugliano R.P. et al. IMPROVE-IT Investigators. Ezetimibe added to statin therapy after acute coronary syndromes // New Engl. J. Med.– 2015.– Vol. 372.– P. 2387–2397. doi:https://doi.org/10.1056/NEJMoa1410489.

Celermajer D.S., Sorensen K.E., Gooch V.M. et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis // Lancet.– 1992.– Vol. 340 (8828).– P. 1111–1115. https://doi.org/10.1016/0140-6736(92)93147-f.

Charakida M., Masi S., Luscher T.F. et al. Assessment of atherosclerosis: the role of flow-mediated dilatation // Eur. Heart J.– 2010.– Vol. 31 (23).– P. 2854–2861. doi:https://doi.org/10.1093/eurheartj/ehq340.

Díez-Delhoyo F., Gutiérrez-Ibañes E., Sanz-Ruiz R. Prevalence of microvascular and endothelial dysfunction in the nonculprit territory in patients with acute myocardial infarction // Circ. Cardiovasc. Interv. – 2019.– Vol. 12 (2). doi: https://doi.org/10.1161/CIRCINTERVENTIONS.118.007257.

Dupuis J., Tardif J.-C., Rouleau J.-L. Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER Trial) // Am. J. Cardiol.– 2005.– Vol. 96 (9).– P. 1207–1213. doi: https://doi.org/10.1016/j.amjcard.2005.06.057.

Flammer A.J., Luscher T.F. Human endothelial dysfunction: EDRFs // Pflugers Arch.– 2010.– Vol. 459 (6).– P. 1005–1013. doi:https://doi.org/10.1007/s00424-010-0822-4.

Fonarow G.C., Wright R.S., Spencer F.A. et al. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality // Amer. J. Cardiol.– 2005.– Vol. 96 (5).– P. 611–616. https://doi.org/10.1016/j.amjcard.2005.04.029.

Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine // Nature.– 1980.– Vol. 288 (5789).– P. 373–376. https://doi.org/10.1038/288373a0.

Garcia M.M., Lima P.R., Correia L.C. Prognostic value of endothelial function in patients with atherosclerosis: systematic review // Arq. Bras. Cardiol.– 2012.– Vol. 99.– P. 857–865. doi: https://doi.org/10.1590/S0066-782X2012005000078.

Ghiadoni L., Taddei S., Virdis A. et al. Endothelial function and common carotid artery wall thickening in patients with essential hypertension // Hypertension.– 1998.– Vol. 32 (1).– P. 25–32. doi:https://doi.org/10.1161/01.hyp.32.1.25.

Gibbons G.H. Cardioprotective mechanisms of ACE inhibition. The angiotensin II-nitric oxide balance // Drugs.– 1997.– Vol. 54 (Suppl 5).– P. 1–11.https://doi.org/10.2165/00003495-199700545-00003.

Gori T., Munzel T. Oxidative stress and endothelial dysfunction: therapeutic implications // Ann. Med.– 2011.– Vol. 43.– P. 259–272; https://doi.org/10.3109/07853890.2010.543920.

Harris R.A., Nishiyama S.K., Wray D.W., Richardson R.S. Ultrasound assessment of flow-mediated dilation // Hypertension.– 2010.– Vol. 55 (5).– P. 1075–1085. https://doi.org/10.1161/HYPERTENSIONAHA.110.150821.

Harrison D.G., Armstrong M.L., Freiman P.C., Heistad D.D. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis // J. Clin. Invest.– 1987.– Vol. 80 (6).– P. 1808–1811. doi: https://doi.org/10.1172/JCI113276.

Heitzer T., Schlinzig T., Krohn K. et al. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease // Circulation.– 2001.– Vol. 104 (22).– P. 2673–2678. https://doi.org/10.1161/hc4601.099485.

Joannides R., Haefeli W.E., Linder L. et al. Nitric oxide is responsible for flow-dependent dilatation of human peri­­pheral conduit arteries in vivo // Circulation.– 1995.– Vol. 91 (5).– P. 1314–1319. doi: https://doi.org/10.1161/01.cir.91.5.1314.

Joannides R., Richard V., Haefeli W.E. et al. Role of basal and stimulated release of nitric oxide in the regulation of radial artery caliber in humans // Hypertension.– 1995.– Vol. 26 (2).– P. 327–331. https://doi.org/10.1161/01.hyp.26.2.327.

Lieberman E.H., Gerhard M.D., Uehata A. et al. Flow-induced vasodilation of the human brachial artery is impaired in patients < 40 years of age with coronary artery disease // Am. J. Cardiol.– 1996.– Vol. 78 (11).– P. 1210–1214. https://doi.org/10.1016/s0002-9149(96)00597-8.

Linder L., Kiowski W., Buhler F.R., Luscher T.F. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension // Circulation.– 1990.– Vol. 81 (6).– P. 1762–1767. doi: https://doi.org/10.1161/01.cir.81.6.1762.

Ludmer P.L., Selwyn A.P., Shook T.L. et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries // New Engl. J. Med.– 1986.– Vol. 315 (17).– P. 1046–1051. doi: https://doi.org/10.1136/hrt.77.4.297.

Luscher T.F., Noll G. The pathogenesis of cardiovascular disease: role of the endothelium as a target and mediator // Atherosclerosis.– 1995.– Vol. 118 (Suppl. S).– P. 81–90.

Matsuzawa Y., Sugiyama S., Sumida H. et al. Peripheral endothelial function and cardiovascular events in high-risk patients // J. Am. Heart Assoc.– 2013.– Vol. 2 (6). https://doi.org/10.1161/JAHA.113.000426.

Montone R.A., Niccoli G., Fracassi F. Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests // Eur. Heart J.– 2018.– Vol. 39 (2).– P. 91–98. https://doi.org/10.1093/eurheartj/ehx667.

Morizzo C., Kozakova M., Bartolomucci F. et al. Carotid artery remodeling is associated to coronary multivessel disease but not to clinical events in patients with stable ischemic heart disease // J. Hypertens.– 2004.– Vol. 22.– P. S60–61.

Parker B.A., Tschakovsky M.E., Augeri A.L. et al. Heterogenous vasodilator pathways underlie flow-mediated dilation in men and women // Am. J. Physiol. Heart Circ. Physiol.– 2011.– Vol. 301 (3).– P. 1118–1126. https://doi.org/10.1152/ajpheart.00400.2011.

Perticone F., Ceravolo R., Pujia A. et al. Prognostic significance of endothelial dysfunction in hypertensive patients // Circulation.– 2001.– Vol. 104 (2).– P. 191–196. https://doi.org/10.1161/01.cir.104.2.191.

Schachinger V., Britten M.B., Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease // Circulation.– 2000.– Vol. 101 (16).– P. 1899–1906. https://doi.org/10.1161/01.cir.101.16.1899.

Schnabel R.B., Schulz A., Wild P.S. et al. Noninvasive vascular function measurement in the community: cross-sectional relations and comparison of methods // Circ. Cardiovasc.– 2011.– Im. 4.– P. 371–380. https://doi.org/10.1161/CIRCIMAGING.110.961557.

Steven S., Munzel T., Daiber A. Exploiting the pleiotropic antioxidant effects of established drugs in cardiovascular disease // Int. J. Mol.– 2015.– Vol. 16.– P. 18185–18223. https://doi.org/10.3390/ijms160818185.

Suessenbacher A., Dorler J., Wunder J. et al. Comparison of brachial artery wall thickness versus endothelial function to predict late cardiovascular events in patients undergoing elective coronary angiography // Am. J. Cardiol.– 2013.– Vol. 111.– P. 671–675. https://doi.org/10.1016/j.amjcard.2012.11.020.

Taddei S. Aging and endothelial function // Cardiologia.– 1997.– Vol. 42 (12).– P. 1229–1236.

Takase S., Matoba T., Nakashiro S. Ezetimibe in Combina­­tion With Statins Ameliorates Endothelial Dysfunction in Coronary Arteries After Stenting // Arteriosclerosis, Thrombosis, and Vascular Biology.– 2017.– Vol. 37.– P. 350–358. https://doi.org/10.1161/ATVBAHA.116.308388.

Tamai O., Matsuoka H., Itabe H. et al. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans // Circulation.– 1997.– Vol. 95 (1).– P. 76–82. doi: https://doi.org/10.1161/01.cir.95.1.76.

Thijssen D.H., Black M.A., Pyke K.E. et al. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline // Am. J. Physiol. Heart Circ. Physiol.– 2011.– Vol. 300 (1).– Р. H2–12. https://doi.org/10.1152/ajpheart.00471.2010.

Most read articles by the same author(s)

1 2 3 > >>